• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Deep (Brain) Thoughts with Medtronic's Neuromodulation President

    Grab and Go: Examining the Thrombectomy Device Market

    Fine Print: A Discourse on Additive Manufacturing

    MPO's 2022 Medtech Industry Year in Review

    Micro Molding for Medtech Is Miniature Magic
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Regulatory
    Financial/Business
    Top News
    Japanese Universities Start Joint Trials for Fall Detection Tech

    FDA Clears H2o Therapeutics' Parkinson's Disease Monitoring App

    MICRO's Costa Rica Facility Achieves ISO 13485:2016 Certification

    FDA Clears SafeSource Direct's Nitrile Exam Gloves

    Baxter, Miromatrix Team Up for Bioengineered Liver
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Deep (Brain) Thoughts with Medtronic's Neuromodulation President

    Grab and Go: Examining the Thrombectomy Device Market

    Fine Print: A Discourse on Additive Manufacturing

    MPO's 2022 Medtech Industry Year in Review

    Micro Molding for Medtech Is Miniature Magic
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Reflections on 2022 and What’s Ahead for Medtech: MPO Sounding Board

    3 Ways to Prepare for ISO 13485/Part 820 Harmonization

    A New Home for Theranos' Elizabeth Holmes?

    Health Cost Drivers for Large Employers

    Braving Change: Facing Fears in the Midst of Major Transitions
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    Arthur G. Russell Co. Inc., The

    Fusion Biotec Inc.

    Forefront Medical Technology

    NDH Medical Inc.

    Providence Enterprise USA Inc.
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    How Artificial Intelligence Can Combat Key Issues Impacting Healthcare

    Why Advanced Sensors Are Crucial Within Medical Pumps

    How Artificial Intelligence Could Help Prevent 80% of Chronic Diseases

    4 Ways to Use Injection Molding in Medical Device Manufacturing

    Telemedicine and Connectivity to Drive Material Innovation in the Near Future
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    Arthur G. Russell Co. Inc., The

    Fusion Biotec Inc.

    Forefront Medical Technology

    NDH Medical Inc.

    Providence Enterprise USA Inc.
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • eBook
    • Resources
    • Podcasts
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Columns

    The Regulatory Outlook for 2019

    ...

    The Regulatory Outlook for 2019
    Related CONTENT
    • MEDICAL & BIOTECH MANUFACTURING
    • Hyperfine Names Paykel, Teisseyre to Executive Leadership Roles
    • Accu-Tube Appoints Matthew Haddle as CEO
    • Heraeus Acquires Mo-Sci Corporation, ETS Technology Holdings
    • CE Mark Granted to Predictive Software for Kidney Allograft Survival
    James A. Dunning, Principal, QPC Services LLC11.26.18
    Time seems to have passed more quickly for me this year than at any other period in my life. I’m still not sure why, but one contributing factor could be the volume and gravity of regulatory changes that have been looming on the horizon. This is the time of year when I like to take a step back to focus—or refocus, rather—on what lies ahead. Some of the specific regulatory changes that have significantly impacted many medical device companies already or will affect them in the near future include the European Medical Device Regulations (MDR)—(EU) 2017/745; the In Vitro Device Regulation (IVDR); the Medical Device Single Audit Program (MDSAP); and ISO 13485:2016 revision. 

    Medical Device Regulation 
    Regulatory requirements for medical devices in the European Union have remained fairly constant since the mid 1990s, but this is no longer the case. The MDR is the new rule that replaces the European Union’s Medical Device Directive (MDD). Healthcare companies have until the end of May 2020 to transition to this new decree. The new MDR is significantly different than its predecessor. Compliance with the MDR will be much more difficult than it has been in the past—since there is no “grandfathering” for existing products, all manufacturers will need to review their current devices against the regulation’s requirements. Manufacturers that want an assessment against the new MDR will need to apply to a Notified Body for the evaluation. Though it might seem like a long way off, organizations should start preparing now for the MDR.

    Key changes included in the new MDR are:
    • A wider scope of regulated medical devices
    • At least one person responsible for regulatory compliance
    • Definition of common specifications
    • More stringent clinical evidence and documentation
    • Increased focus on identification and traceability
    • Unannounced factory audits
    • Increased Notified Body authority and/or involvement
    • More rigorous vigilance and market surveillance
    In Vitro Diagnostics Regulations
    Like the MDR, the new In Vitro Device Regulation (IVDR) transition period ends in May 2022 as well. The changes in the IVDR are significant, because the existing In Vitro Device Directive was written for a relatively young industry. The new Regulation addresses some of the challenges posed by the Directive, including a new rule-based classification system for products, superseding the current list-based approach. This makes the Regulation more practical by allowing it to remain relevant to an innovative and growing industry. However, it also will require a far larger number of IVD manufacturers to seek notified body certification for their products because classification rules will now be applied to all in vitro diagnostics, as opposed to those restricted to exclusive lists. Under the IVD Directive, 90 percent of the industry could self-certify, but with the Regulation, up to 90 percent of the industry will require Notified Body certification. The IVDR places a much greater focus on clinical evaluation, and increased control over the wider supply chain.

    The Medical Device Single Audit Program
    The International Medical Device Regulators Forum has created a harmonized approach to auditing and monitoring medical device manufacturing. This new approach is designed to improve the safety and oversight of medical device manufacturing on an international scale.  As a result, the Medical Device Single Audit Program (MDSAP), was established. The MDSAP has a sequential approach. The audit sequence contains four primary processes (Management; Measurement, Analysis, and Improvement; Design and Development; and Production and Service Controls), an enabling process (Purchasing), and two supporting processes (Device Marketing Authorization and Facility Registration, and Medical Device Adverse Events and Advisory Notice Reporting). The primary processes are built on a foundation of risk management requirements. Each MDSAP process area includes audit objectives and a series of tasks that auditors use to determine ISO 13485 compliance (the current 13485:2003 standard expires on March 1, 2019, at which time the 2016 revision becomes effective) and the applicable regulatory requirements of the countries participating in the program—Australia, Brazil, Canada, Japan, and the United States. Official MDSAP observers are the World Health Organization, the Medicines and Healthcare Products Regulatory Agency, and the Health Products Regulatory Authority; these agencies’ participation give a hint of the MDSAP’s potential growth.

    The MDSAP’s initial pilot phase began in January 2014. The pilot phase is over, and the program’s implementation is now occurring. Health Canada, for instance, is requiring medtech manufacturers to transition to the MDSAP in order to maintain compliance with the quality management system (QMS) requirements of the Canadian Medical Devices Regulations. As of Jan. 1, 2019, only MDSAP certificates will be accepted in Canada. Also, the U.S. Food and Drug Administration (FDA) has confirmed that it will accept the MDSAP audit report as a substitute for routine agency inspections. Reviews conducted “For Cause” or “Compliance Follow-up” by FDA will not be affected by this program; the MDSAP will not apply to any necessary pre-approval or post-approval inspections for FDA premarket approval applications. (Editor’s Note: For more details on the MDSAP and ISO 13485:2016 certification deadlines, read MPO’s Year in Review feature on page 42).

    ISO 13485:2016
    Medtech companies that have not yet been certified to the new ISO 13485:2016 standard may not receive their accreditation by the March 1, 2019, deadline because demand is exceeding supply. Simply stated: There are not enough registrars to provide certification services. I expect to be contacted momentarily by companies that are in serious jeopardy of missing the certification deadline, and quite frankly, I’m not sure how I’ll advise them. I have never witnessed a situation like this before, though procrastination is partly at fault here (companies have had three years to get certified to the updated standard). Nevertheless, the dilemma sometimes keeps me up at night. Companies that hope to achieve ISO 13485:2016 certification by the deadline must act immediately and make arrangements (if possible) with a registrar. Finding a registrar with the bandwidth to certify an application by the deadline will be challenging, however.

    Since I don’t want to end this section on a sour note, I’d like to highlight some of the good things about ISO 13485:2016. This list is not intended to be comprehensive, but it does focus on some of the most significant changes in the revised standard. Those changes include:

    Risk
    The ISO 13485:2016 standard expects companies to apply a “risk based approach” to its QMS processes. ISO 13485:2003 expected firms to think about risk, but only during product realization (in section 7). But now, organizations are expected to apply risk management methods and techniques to all QMS processes, including outsourced practices. For example, for purchased products, ISO 13485:2016 requires companies to consider the risk associated with a purchased product, formulate an action plan for unanticipated product changes, and determine whether the changes affect the medical device or the product realization process.

    Medical Device File
    While both ISO 13485:2003 and ISO 13485:2016 expect companies to establish a special file for each type of medical device, the 2016 revision clarifies exactly what this means. Organizations are now expected to include a description of each medical device or family of devices and to include all associated specifications, procedures, and records.

    Training
    While the 13485:2003 standard focused on the need to identify product requirements specified by customers and regulatory bodies, ISO 13485:2016 requires companies to also think about product safety and performance; it also commands manufacturers to consider the associated training needs of product users and to verify that regulatory requirements will be met and user training will be available before products are supplied to customers.

    Servicing
    The servicing section in ISO 13485:2016 has also changed. Besides documenting its servicing procedures and reference materials, companies also are now expected to analyze servicing records in order to identify servicing complaints and improvement opportunities.

    There is so much more to these regulations that I have left out (it’s impossible to comprehensively summarize all the changes in 1,600 words). My intent was not to cover all of the upcoming changes, but rather to highlight those I believe are the most important. I attended the 2018 MPO Summit, where the near-term regulatory changes were described as a perfect storm. This is a very good and accurate description of what the medtech industry is currently facing. I hope companies are fully prepared for these changes, but if not, perhaps this column can help them initiate the necessary actions to get ready as quickly as possible. The train is racing down the track. We can stop it; we all just have to get on board. 


    James A. “Jim” Dunning’s consulting career began in 2001. He has provided quality and regulatory consulting services for various companies ranging from Fortune 500 medical device firms to startups. Dunning’s passion, however, lies with startups and small companies, especially those in regulatory distress. He has amassed significant experience in preparing 510(k) applications, developing complete Quality Management Systems, providing Quality System Training, and advising on quality, business, and leadership issues. Dunning is a senior member of the American Society for Quality (ASQ) and a member of the Regulatory Affairs Professional Society (RAPS). He can be reached at jdunning@qpcservices.com. 
    Related Searches
    • medical device companies
    • supply chain
    • user
    • body
    Suggested For You
    MEDICAL & BIOTECH MANUFACTURING MEDICAL & BIOTECH MANUFACTURING
    Hyperfine Names Paykel, Teisseyre to Executive Leadership Roles Hyperfine Names Paykel, Teisseyre to Executive Leadership Roles
    Accu-Tube Appoints Matthew Haddle as CEO Accu-Tube Appoints Matthew Haddle as CEO
    Heraeus Acquires Mo-Sci Corporation, ETS Technology Holdings Heraeus Acquires Mo-Sci Corporation, ETS Technology Holdings
    CE Mark Granted to Predictive Software for Kidney Allograft Survival CE Mark Granted to Predictive Software for Kidney Allograft Survival
    Electroducer Raises 3 Million Euros to Market Heart Valve Disease Tech Electroducer Raises 3 Million Euros to Market Heart Valve Disease Tech
    Precision Coating Merges with N2 Biomedical Precision Coating Merges with N2 Biomedical
    Medical Devices Market to Top $671.49 Billion by 2027 Medical Devices Market to Top $671.49 Billion by 2027
    Indago Announces $10 Million Financing Close and Name Change Indago Announces $10 Million Financing Close and Name Change
    Molli Surgical Molli Surgical's Breast Tumor Marker
    Vertigo Treatment Receives FDA Breakthrough Device Designation Vertigo Treatment Receives FDA Breakthrough Device Designation
    RapidPulse Closes $15 Million Series A Financing RapidPulse Closes $15 Million Series A Financing
    Midwest Products & Engineering Acquires MindFlow Design Midwest Products & Engineering Acquires MindFlow Design
    Vicarious Surgical Opens New Corporate Headquarters in Massachusetts Vicarious Surgical Opens New Corporate Headquarters in Massachusetts
    Luis J. Malavé Joins Integrity Applications Board Luis J. Malavé Joins Integrity Applications Board

    Related Literature / Brochures

    • MEDICAL & BIOTECH MANUFACTURING

      ISO 13485:2016 • FDA Registered

    • Hyperfine Names Paykel, Teisseyre to Executive Leadership Roles

      Hyperfine Names Paykel, Teisseyre to Executive Leadership Roles

      Neela Paykel is serving as general counsel and Tom Teisseyre assumes the chief product officer position.
      Business Wire 09.22.21

    • Tubing & Extrusion
      Accu-Tube Appoints Matthew Haddle as CEO

      Accu-Tube Appoints Matthew Haddle as CEO

      Haddle has a track record of leading organizations through strategic expansions across the medical device, aerospace, and industrial sectors.
      Accu-Tube 09.22.21


    • Heraeus Acquires Mo-Sci Corporation, ETS Technology Holdings

      Heraeus Acquires Mo-Sci Corporation, ETS Technology Holdings

      The two deals will strengthen Heraeus' healthcare and medtech portfolio.
      Heraeus 09.22.21

    • CE Mark Granted to Predictive Software for Kidney Allograft Survival

      CE Mark Granted to Predictive Software for Kidney Allograft Survival

      Algorithm gives the probability the graft will still be functional at three, five, and seven years after evaluation by a healthcare professional.
      Cibiltech 09.21.21

    Loading, Please Wait..

    Trending
    • The Future Of Biomedical Engineering Advancements
    • Cirtec Medical Corporation Acquires Precision Components Business From QMD
    • Medtronic's Recall Of Mahurkar Catheters Is Class I
    • Coloplast Launches New Catheter In The U.S.
    • A New Approach To Post-Market Surveillance
    Breaking News
    • Japanese Universities Start Joint Trials for Fall Detection Tech
    • FDA Clears H2o Therapeutics' Parkinson's Disease Monitoring App
    • MICRO's Costa Rica Facility Achieves ISO 13485:2016 Certification
    • FDA Clears SafeSource Direct's Nitrile Exam Gloves
    • Baxter, Miromatrix Team Up for Bioengineered Liver
    View Breaking News >
    CURRENT ISSUE

    November 2022

    • MPO's 2022 Year in Review
    • Fine Print: A Discourse on Additive Manufacturing
    • Grab and Go: Examining the Thrombectomy Device Market
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Pycnogenol Supplementation Linked to Hair Density in Menopausal Women
    BAPP Paper Reviews Common Adulteration Practices Which Go Undetected
    CRN Announces Promotions and Welcomes New Staff Member
    Coatings World

    Latest Breaking News From Coatings World

    ROSS Offers Heavy-Duty Three Roll Mills for High Viscosity Dispersions
    PPG Achieves ISO 14001 Certification of Environmental Management System
    AmCoat’s Rhino Shield and Floor Shield Break Records in 2022
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Japanese Universities Start Joint Trials for Fall Detection Tech
    FDA Clears H2o Therapeutics' Parkinson's Disease Monitoring App
    MICRO's Costa Rica Facility Achieves ISO 13485:2016 Certification
    Contract Pharma

    Latest Breaking News From Contract Pharma

    HPNE Launches New Approach to Single-Use Assembly Production
    Andelyn Biosciences, Odylia Therapeutics Partner to Manufacture Gene Therapy for Vision Loss
    Lonza Breaks Ground on Commercial Drug Product Facility in Stein
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Paco Rabanne Launches FAME Fragrance in the U.S.
    Sally Beauty Expands Bondbar Lineup of Hair Care Products
    L’Oréal Group Recognized by Bloomberg Gender-Equality Index 2023
    Happi

    Latest Breaking News From Happi

    Ross Introduces Heavy-Duty Three Roll Mills for High-Viscosity Dispersions
    Perfect Corp Partners with Beekman 1802 for New My Skin Biome Tool
    OPI’s Nature Strong Introduces Botanical Base Coat and New Colors
    Ink World

    Latest Breaking News From Ink World

    C3Nano Offers New SuperGrid Flexible Low-Temperature Ink
    ROSS Develops Heavy-Duty Three Roll Mills for High Viscosity Dispersions
    Alexander's Adds Two New HP Indigo 100K Digital Presses to Fleet
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Baker Labels invests in Digicon 3000 for flexible packaging division
    PIM promotes Kristin Pilling-Davis to executive director
    Stratus Packaging embraces automation with Bobst
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    WPT Nonwovens to Add Thermobonding Line in Kentucky
    Superior Felt & Filtration Adds Domestic Injection Molding to its Medical Filtration Capabilities
    Ahlstrom Launches New Generation FluoroFree Technology
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Solid Growth Ahead for Orthopedic Power Tools Market
    Mobi-C Cervical Disc Replacement Procedures Top 200,000
    OPUM, Corflex Global Partner on Knee Assessment Technology
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Alexander Everke Hands Over ams OSRAM CEO Position to Aldo Kamper
    Angèle Reinders Named New Director of Solliance
    C3Nano Launches New SuperGrid Flexible Low-Temperature Ink

    Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login